Clinical Nurse Specialist Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jean Uy

Clinical Nurse Specialist, Acute Care Houston, TX Clinical Nurse Specialist

NPI 1336247543 CMS profile 10890572

2002 Holcombe Blvd, Houston, TX 77030

Open in the dashboard

General payments

$9,648

185 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jean Uy of Houston, TX is reported in the CMS Open Payments database as having received $9,648 across 185 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Clinical Nurse Specialist, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,289 27
2024 General $3,495 55
2023 General $2,142 55
2022 General $1,328 34
2021 General $395 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jean Uy
  • Clinical Nurse Specialist, Acute Care median
  • Middle half of Clinical Nurse Specialist, Acute Care
  • National median

In program year 2025, general payments to Jean Uy were reported at $2,289. Among 170 Clinical Nurse Specialist, Acute Care profiles paid that year, the median was $137 and the middle half received between $42 and $436.

Show as a table
Year Jean Uy Clinical Nurse Specialist, Acute Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $395 $125 $44–$370 $132
2022 $1,328 $109 $56–$356 $149
2023 $2,142 $126 $43–$435 $160
2024 $3,495 $128 $46–$385 $164
2025 $2,289 $137 $42–$436 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $3,715 57 payments
  2. Boston Scientific Corporation $2,943 28 payments
  3. Medtronic, Inc. $1,118 78 payments
  4. Impulse Dynamics (USA) Inc. $1,000 10 payments
  5. CVRx, Inc. $348 5 payments
  6. Respicardia, Inc. $286 2 payments
  7. Inspire Medical Systems, Inc. $159 1 payment
  8. Lantheus Medical Imaging, Inc. $39 2 payments
  9. Vapotherm Inc $21 1 payment
  10. Cardiva Medical, Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,295 179 payments
  2. Travel and Lodging $1,353 6 payments
Products named General payments · program years 2021–2025
  1. AVEIR Cardiac Rhythm Management $1,395 16 payments
  2. OPTIMIZER Cardiovascular Device $1,000 10 payments
  3. OPTIMIZER Cardiovascular Device $1,000 10 payments
  4. WATCHMAN Access System $489 3 payments
  5. AVEIR Cardiac Rhythm Management $446 5 payments
  6. COBALT DR MRI SURESCAN $433 15 payments
  7. AVEIR Structural Heart $350 5 payments
  8. Barostim Neo System $348 5 payments
  9. GALLANT $319 5 payments
  10. remede System $286 2 payments
  11. Other $3,187 110 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

185 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Nurse Specialist, Acute Care in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record